Sept. 2 (Bloomberg) -- DaVita Inc. must sell 29 clinics that provide dialysis services to get U.S. approval for the company’s bid to buy CDSI I Holding Co., the Federal Trade Commission said.
Competition will be preserved in 22 markets with the divestment, which is part of a proposed settlement, the FTC said in a statement.
DaVita is the Denver-based provider of outpatient dialysis services, which are used to treat people with advanced kidney disease, according to the FTC. DaVita is seeking to buy for $689 million Nashville, Tennessee-based CDSI, the fifth-largest provider of such services.
Skip Thurman, a spokesman for DaVita, didn’t immediately return phone calls seeking comment.
To contact the reporter on this story: Jeff Bliss in Washington at email@example.com
To contact the editor responsible for this story: Mark Silva in Washington at firstname.lastname@example.org